Evidence map›Paper›PMID 31034318›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2019

Expression of Different Isoforms of Versican During the Development of Mouse Mandibular First Molars.

Fangfang Xu, Wenping Cai, Weiting Chen, Lefeng Li, Xuyan Li, Beizhan Jiang

Open access · bronzeAbstract read
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Naive CD4iScience · 2026
    Article
  2. Maize Anther Development Involves Translated Open Reading Frames From 3' Untranslated Regions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. V3: an enigmatic isoform of the proteoglycan versican.American journal of physiology. Cell physiology · 2023
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Fangfang XuDepartment of Operative Dentistry and Endodontics, School & Hosipital of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China (FX, WChen, LL, XL, BJ).
Wenping CaiDepartment of Operative Dentistry and Endodontics, School & Hosipital of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China (FX, WChen, LL, XL, BJ).
Weiting ChenDepartment of Operative Dentistry and Endodontics, School & Hosipital of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China (FX, WChen, LL, XL, BJ).
Lefeng LiDepartment of Operative Dentistry and Endodontics, School & Hosipital of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China (FX, WChen, LL, XL, BJ).
Xuyan LiDepartment of Operative Dentistry and Endodontics, School & Hosipital of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China (FX, WChen, LL, XL, BJ).
Beizhan JiangDepartment of Operative Dentistry and Endodontics, School & Hosipital of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China (FX, WChen, LL, XL, BJ).
Shanghai Tenth People's Hospital · CNTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Versican is a large chondroitin sulfate proteoglycan enriched in the extracellular matrix, and it has at least four different isoforms, termed V0, V1, V2, and V3. Although several studies have demonstrated that versican is stably expressed in various developing organs, the expression of versican isoforms during tooth development has not been elucidated yet. Therefore, the present study was to investigate the expression of versican isoforms in the developing mouse molars. The mandibular first molars from embryonic day (E) 11.5 to postnatal day (PN) 21 were used to investigate the expression of versican isoforms by immunohistochemistry, and the gene expressions of versican (

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsFemaleMiceMolarPregnancyProtein IsoformsProtein TransportVersicansProtein IsoformsVersicanscell proliferationchondroitin sulfate proteoglycanscytodifferentiationtooth developmentversican

Identifiers

PMID31034318
PMCPMC6598129
OpenAlexW2942885355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.